Names | |
---|---|
IUPAC name
N2-Pentylglycinamide
| |
Systematic IUPAC name
2-(Pentylamino)acetamide[1] | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
MeSH | milacemide |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C7H16N2O | |
Molar mass | 144.218 g·mol−1 |
log P | 0.754 |
Related compounds | |
Related compounds
|
Tricine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Milacemide (INN)[2] is an MAO-B inhibitor and glycine prodrug.[3] It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease.[4] Early clinical trials did not show positive results however,[3] and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.[5]
{{cite book}}
: CS1 maint: multiple names: authors list (link)